Exclusion of patients with brain metastases from cancer clinical trials
Neuro Oncol
.
2020 Apr 15;22(4):577-579.
doi: 10.1093/neuonc/noz246.
Authors
Roshal R Patel
1
2
,
Vivek Verma
1
,
Austin B Miller
1
3
,
Timothy A Lin
4
,
Amit Jethanandani
5
,
Andres F Espinoza
6
,
Walker Mainwaring
6
,
Alexander Augustyn
1
,
C David Fuller
1
,
Erik P Sulman
7
,
Debra N Yeboa
1
,
Caroline C Chung
1
,
Mary Frances McAleer
1
,
Jing Li
1
,
Daniel Yoshor
6
,
John F de Groot
1
,
Jacob J Mandel
6
,
Ethan B Ludmir
1
Affiliations
1
The University of Texas MD Anderson Cancer Center, Houston, Texas.
2
Albany Medical College, Albany, New York.
3
The University of Texas Health Science Center McGovern Medical School, Houston, Texas.
4
The Johns Hopkins University School of Medicine, Baltimore, Maryland.
5
The University of Tennessee Health Science Center College of Medicine, Memphis, Tennessee.
6
Baylor College of Medicine, Houston, Texas.
7
New York University Langone School of Medicine, New York, New York.
PMID:
31900480
PMCID:
PMC7158639
DOI:
10.1093/neuonc/noz246
No abstract available
Publication types
Letter
MeSH terms
Brain Neoplasms* / therapy
Cranial Irradiation
Humans
Lung Neoplasms*